Relationship between imidazoline and α2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents

Journal of the Autonomic Nervous System

Volumn 72, Issue 2-3, 1998, Pages 163-169

  Head, Geoffrey A ^a   Chan, Candy K S ^a   Burke, Sandra L ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

2 adrenoceptors; Central noradrenergic neurons; Clonidine; Idazoxan; Imidazoline receptors; Moxonidine methylnoradrenaline; Rilmenidine; Rostroventrolateral medulla

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; CLONIDINE; IMIDAZOLINE RECEPTOR; METHYLDOPA; MOXONIDINE; NEUROTOXIN; RILMENIDINE; ADRENERGIC RECEPTOR BLOCKING AGENT; DRUG RECEPTOR; IMIDAZOLE DERIVATIVE; IMIDAZOLINE RECEPTORS; SEROTONIN;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; MEDULLA OBLONGATA; NERVE ENDING; NONHUMAN; NORADRENERGIC SYSTEM; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RABBIT; ANIMAL; BRAIN; DRUG EFFECT; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BRAIN; IMIDAZOLES; MEDULLA OBLONGATA; RABBITS; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, DRUG; SEROTONIN; SYMPATHOLYTICS;

EID: 0031593635     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(98)00101-5     Document Type: Conference Paper

References (40)

1. Badoer, E., Head, G.A., Korner, P.I., 1983. Effects of intracisternal and intravenous α-methyldopa and clonidine on haemodynamics and baroreceptor-heart rate reflex properties in conscious rabbits. J. Cardiovasc. Pharmacol. 5, 760-767.
2. Bousquet, P., Guertzenstein, P.G., 1973. Localization of the central cardiovascular action of clonidine. Br. J. Pharmacol. 49, 573-579.
3. Bousquet, P., Feldman, J., Bloch, R., Schwartz, J., 1981. The nucleus reticularis lateralis: a region highly sensitive to clonidine. Eur. J. Pharmacol. 69, 389-392.
4. Bousquet, P., Feldman, J., Schwartz, J., 1984. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230, 232-236.
5. Chan, C.K.S., Head, G.A., 1996. Relative importance of central imidazoline receptors for the anti-hypertensive effects of moxonidine and rilmenidine. J. Hypertens. 14, 855-864.
6. Chan, C.K.S., Sannajust, F., Head, G.A., 1996. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits. J. Pharmacol. Exp. Ther. 276, 411-420.
7. 1 receptor and the pharmacology of imidazolines. Cardiovascular Drugs and Therapy 8, 21-26.
8. Dorward, P.K., Riedel, W., Burke, S.L., Gipps, J., Korner, P.I., 1985. The renal sympathetic baroreflex in the rabbit. Arterial and cardiac baroreceptor influences, resetting, and effect of anesthesia. Circ. Res. 57, 618-633.
9. Ernsberger, P., Guiliano, R., Willette, R.N., Reis, D.J., 1990. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253, 408-418.
10. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20, S1-S10, Suppl. 4.
11. 1-imidazoline sites. J. Pharmacol. Exp. Ther. 264, 172-182.
12. 1 receptors in the ventrolateral medulla and their role in cardiorespiratory control. In: Trouth, C.O., Millis, R.M., (Eds.), Ventral Brainstem Mechanisms and Control of Respiration and Blood Pressure, Marcel Dekker, Washington, pp. 319-358.
13. Ernsberger, P., Friedman, J.E., Koletsky, R.J., 1997. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens. 15, S9-S23, Suppl.
14. Feldman, J., Tibirica, E., Bricca, G., Dontenwill, M., Belcourt, A., Bousquet, P., 1990. Evidence for the involvement of imidazoline receptors in the central hypotensive effect of rilmenidine in the rabbit. Br. J. Pharmacol. 100, 600-604.
15. Finch, L., Haeusler, G., 1973. Further evidence for a central hypotensive action of α-methyldopa in both the rat and cat. Br. J. Pharmacol. 47, 217-228.
16. Gomez, R.E., Ernsberger, P., Feinland, G., Reis, D.J., 1991. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area. Eur. J. Pharmacol. 195, 181-191.
17. Guyenet, P.G., 1997. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am. J. Physiol. Regul. Integr. C 42, R1580-R1584.
18. 2-adrenergic receptors rather than 'imidazoline' binding sites mediate the sympatholytic effect of clonidine in the rostral ventrolateral medulla: a new look at the evidence. In: Trouth, O., Millis, R., Kiwull-Schone, H., Schlafke, M.E. (Eds.), Ventral Brainstem Mechanisms and Control Functions, Marcel Dekker, New York, pp. 281-303.
19. Head, G.A., 1995. Central monoamine systems and new antihypertensive agents. Clin. Exp. Hypertens. 17, 141-152.
20. Head, G.A., Burke, S.L., 1991. Importance of central noradrenergic and serotonergic pathways in the cardiovascular actions of rilmenidine and clonidine. J. Cardiovasc. Pharmacol. 18, 819-826.
21. Head, G.A., Burke, S.L., 1998. Relative importance of medullary brain nuclei for the sympatho-inhibitory actions of rilmenidine in the anaesthetised rabbit. J. Hypertens. 16, 503-517.
22. Head, G.A., de Jong, W., 1985. Central vs. peripheral adrenergic regulation of blood pressure: contributions to the actions of alpha-methyldopa. In: Birkinhager, W., Struyker-Boudier, F.B., Struyker-Boudier, H. (Eds.), Adrenergic Blood Pressure Regulation, Excerpta Medica, Amsterdam, pp. 103-113.
23. Head, G.A., Sannajust, F., 1992. Importance of imidazoline receptors in the cardiovascular responses to clonidine and rilmenidine in conscious rabbits. Fundam. Clin. Pharmacol. 6, 31s-43s, Suppl 1.
24. Head, G.A., Korner, P.I., Lewis, S.L., Badoer, E., 1983. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and α-methyldopa in rabbits. J. Cardiovasc. Pharmacol. 5, 945-953.
25. Head, G.A., Godwin, S.J., Sannajust, F., 1993. Differential receptors involved in the cardiovascular effects of clonidine and rilmenidine in conscious rabbits. J. Hypertens. 11, S322-S323, suppl. 5.
26. Isaac, L., 1980. Clonidine in the central nervous system: site and mechanism of hypotensive action. J. Cardiovasc. Pharmacol. 2, S5-S19.
27. 2A-adrenoceptors. Eur. J. Pharmacol. 167, 95-104.
28. Lipski, J., Przybylski, J., Solnicka, E., 1976. Reduced hypotensive effect of clonidine after lesions of the nucleus tractus solitarii in rats. Eur. J. Pharmacol. 38, 19-22.
29. 2A-adrenergic receptor subtype. Science 273, 801-803.
30. Munk, S.A., Lai, R.K., Burke, J.E., Arasasingham, P.N., Kharlamb, A.B., Manlapaz, C.A., Padillo, E.U., Wijono, M.K., Hasson, D.W., Wheeler, L.A., Garst, M.E., 1996. Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazolinel receptor specific agent. J. Med. Chem. 39, 1193-1195.
31. Punnen, S., Urbanski, R., Krieger, A.J., Sapru, H.N., 1987. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 422, 336-346.
32. Reynoldson, J.A., Head, G.A., Korner, P.I., 1979. Effect of 6-hydroxydopamine on blood pressure and heart rate responses to intracisternal clonidine in conscious rabbits. Eur. J. Pharmacol. 55, 257-262.
33. Sannajust, F., Head, G.A., 1993. Effect of rilmenidine on the baroreflex control of renal sympathetic nerve activity. J. Hypertens. 11, S328-S329, Suppl. 5.
34. Sannajust, F., Head, G.A., 1994. Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors. J. Cardiovasc. Pharmacol. 23, 42-50.
35. 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine. J. Cardiovasc. Pharmacol. 16, 15-22.
36. Stornetta, R.L., Huangfu, D., Rosin, D.L., Lynch, K.R., Guyenet, P.G., 1995. Alpha-2 adrenergic receptors: Immunohistochemical localization and role in mediating inhibition of adrenergic RVLM presympathetic neurons by catecholamines and clonidine. In: Reis, D.J., Bousquet, P., Parini, A. (Eds.), The Imidazoline Receptor Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine. The New York Academy of Sciences, New York, Vol. 763, pp. 541-551.
37. 1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine. Arzneimittelforschung 47, 1009-1015.
38. 2-adrenoceptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 348, 593-600.
39. U'Prichard, D.C., Bechtel, W.D., Rouot, B.M., Snyder, S.H., 1979. Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine. Mol. Pharmacol. 16, 47-60.
40. Urban, R., Szabo, B., Starke, K., 1994. Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors? J. Pharmacol. Exp. Ther. 270, 572-578.